Indole derivatives as NMDA antagonists
    1.
    发明授权
    Indole derivatives as NMDA antagonists 失效
    吲哚衍生物作为NMDA拮抗剂

    公开(公告)号:US5962496A

    公开(公告)日:1999-10-05

    申请号:US86522

    申请日:1998-05-29

    摘要: This invention relates to compounds of formula ##STR1## or a salt, or metabolically labile ester thereof wherein R represents a group selected from halogen, alkyl, alkoxy, amino, alkylamino, dialkylamino, hydroxy, trifluoromethyl, trifluoromethoxy, nitro, cyano, SO.sub.2 R.sub.2 or COR.sub.2 wherein R.sub.2 represents hydroxy, methoxy, amino, alkylamino, or dialkylamino; m is zero or an integer 1 or 2;R.sub.1 represents a cycloalkyl, bridged cycloalkyl, heteroaryl, bridged heterocyclic or optionally substituted phenyl or fused bicyclic carbocylic group;A represents a C.sub.1-4 alkylene chain or the chain (CH.sub.2).sub.p Y(CH.sub.2).sub.q wherein Y is O, S(O)n or NR.sub.3 and which chains may be substituted by one or two groups selected from C.sub.1-6 alkyl optionally substituted by hydroxy, amino, alkylamino or dialkylamino, or which chains may be substituted by the group=O;R.sub.3 represents hydrogen, alkyl or a nitrogen protecting group;n is zero or an integer from 1 to 2;p is zero or an integer from 1 to 3;q is zero or an integer from 1 to 3 with the proviso that the sum of p+q is 1, 2 or 3, which are antagonists of excitatory amino acids, to processes for the preparation and to other use in medicine.

    摘要翻译: 本发明涉及式或其盐或其代谢不稳定酯的化合物,其中R表示选自卤素,烷基,烷氧基,氨基,烷基氨基,二烷基氨基,羟基,三氟甲基,三氟甲氧基,硝基,氰基,SO 2 R 2或COR 2的基团,其中R 2 表示羟基,甲氧基,氨基,烷基氨基或二烷基氨基; m为零或整数1或2; R 1表示环烷基,桥连环烷基,杂芳基,桥连杂环或任选取代的苯基或稠合双环碳酰基; A表示C 1-4亚烷基链或链(CH 2)p Y(CH 2)q,其中Y是O,S(O)n或NR 3,哪些链可以被选自任选被羟基取代的C 1-6烷基中的一个或两个基团取代 ,氨基,烷基氨基或二烷基氨基,或哪些链可以被基团= O取代; R3表示氢,烷基或氮保护基; n为0或1至2的整数; p为0或1至3的整数; q为0或1至3的整数,条件是p + q的和为1,2或3,它们是兴奋性氨基酸的拮抗剂,用于制备和在医药中的其它用途。

    Indole derivatives
    2.
    发明授权
    Indole derivatives 有权
    吲哚衍生物

    公开(公告)号:US6100289A

    公开(公告)日:2000-08-08

    申请号:US374982

    申请日:1999-08-16

    摘要: This invention relates to compounds of formula ##STR1## or a salt, or metabolically labile ester thereof wherein R represents a group selected from halogen, alkyl, alkoxy, amino, alkylamino, dialkylamino, hydroxy, trifluoromethyl, trifluoromethoxy, nitro, cyano, SO.sub.2 R.sub.2 or COR.sub.2 where R.sub.2 represents hydroxy, methoxy, amino, alkylamino, or dialkylamino; m is zero or an integer 1 or 2;R.sub.1 represents a cycloalkyl, bridged cycloalkyl, heteroaryl, bridged heterocyclic or optionally substituted phenyl or fused bicyclic carbocylic group;A represents a C.sub.1-4 alkylene chain or the chain (CH.sub.2).sub.p Y(CH.sub.2).sub.q wherein Y is O, S(O)n or NR.sub.3 and which chains may be substituted by one or two groups selected from C.sub.1-6 alkyl optionally substituted by hydroxy, amino, alkylamino or dialkylamino, or which chains may be substituted by the group .dbd.O;R.sub.3 represents hydrogen, alkyl or a nitrogen protecting group;n is zero or an integer from 1 to 2;p is zero or an integer from 1 to 3;q is zero or an integer from 1 to 3 with the proviso that the sum of p+q is 1, 2 or 3, which are antagonists of excitatory amino acids, to processes for the preparation and to other use in medicine.

    摘要翻译: 本发明涉及式或其盐或其代谢不稳定酯的化合物,其中R表示选自卤素,烷基,烷氧基,氨基,烷基氨基,二烷基氨基,羟基,三氟甲基,三氟甲氧基,硝基,氰基,SO2R2或COR2的基团,其中R2 表示羟基,甲氧基,氨基,烷基氨基或二烷基氨基; m为零或整数1或2; R 1表示环烷基,桥连环烷基,杂芳基,桥连杂环或任选取代的苯基或稠合双环碳酰基; A表示C 1-4亚烷基链或链(CH 2)p Y(CH 2)q,其中Y是O,S(O)n或NR 3,哪些链可以被选自任选被羟基取代的C 1-6烷基中的一个或两个基团取代 ,氨基,烷基氨基或二烷基氨基,或哪些链可以被基团= O取代; R3表示氢,烷基或氮保护基; n为0或1至2的整数; p为0或1至3的整数; q为0或1至3的整数,条件是p + q的和为1,2或3,它们是兴奋性氨基酸的拮抗剂,用于制备和在医药中的其它用途。

    Indole derivatives
    3.
    发明授权
    Indole derivatives 失效
    吲哚衍生物

    公开(公告)号:US5760059A

    公开(公告)日:1998-06-02

    申请号:US619510

    申请日:1996-03-29

    摘要: This invention relates to compounds of formula ##STR1## or a salt, or metabolically labile ester thereof wherein R represents a group selected from halogen, alkyl, alkoxy, amino, alkylamino, dialkylamino, hydroxy, trifluoromethyl, trifluoromethoxy, nitro, cyano, SO.sub.2 R.sub.2 or COR.sub.2 wherein R.sub.2 represents hydroxy, methoxy, amino, alkylamino, or dialkylamino; m is zero or an integer 1 or 2; R.sub.1 represents a cycloalkyl, bridged cycloalkyl, heteroaryl, bridged heterocyclic or optionally substituted phenyl or fused bicyclic carbocylic group; A represents a C.sub.1-4 alkylene chain or the chain (CH.sub.2).sub.p Y(CH.sub.2).sub.q wherein Y is O, S(O)n or NR.sub.3 and which chains may be substituted by one or two groups selected from C.sub.1-6 alkyl optionally substituted by hydroxy, amino, alkylamino or dialkylamino, or which chains may be substituted by the group .dbd.O; R.sub.3 represents hydrogen, alkyl or a nitrogen protecting group; n is zero or an integer from 1 to 2; p is zero or an integer from 1 to 3; q is zero or an integer from 1 to 3 with the proviso that the sum of p+q is 1, 2 or 3, which are antagonists of excitatory amino acids, to processes for the preparation and to other use in medicine.

    摘要翻译: PCT No.PCT / EP94 / 03359 371日期:1996年3月29日 102(e)1996年3月29日PCT 1994年10月12日PCT PCT。 出版物WO95 / 10517 日期1995年4月20日本发明涉及式(I)化合物或其盐或其代谢不稳定的酯,其中R表示选自卤素,烷基,烷氧基,氨基,烷基氨基,二烷基氨基,羟基,三氟甲基, 三氟甲氧基,硝基,氰基,SO2R2或COR2,其中R2表示羟基,甲氧基,氨基,烷基氨基或二烷基氨基; m为零或整数1或2; R 1表示环烷基,桥连环烷基,杂芳基,桥连杂环或任选取代的苯基或稠合双环碳酰基; A表示C 1-4亚烷基链或链(CH 2)p Y(CH 2)q,其中Y是O,S(O)n或NR 3,哪些链可以被选自任选被羟基取代的C 1-6烷基中的一个或两个基团取代 ,氨基,烷基氨基或二烷基氨基,或哪些链可以被基团= O取代; R3表示氢,烷基或氮保护基; n为0或1至2的整数; p为0或1至3的整数; q为0或1至3的整数,条件是p + q的和为1,2或3,它们是兴奋性氨基酸的拮抗剂,用于制备和在医药中的其它用途。